Year: 2014
Type: article
Abstract: The knowledge of the exact tumor stage is essential to adapt therapeutic strategies or to follow the evolution of the tumor after therapy in order to increase the survival chance. The multi-tasking diagnostics that combine techniques such as PET and MRI could really improve imaging tumor stage. PET mainly offers functional information about the disease with high sensitivity. MRI offers predominantly morphological infor-mation, able to provide an excellent soft tissue contrasts due to its high resolution. In this setting, we propose a polysiloxane nanoplatform gadolinium-based (AGuIX®) inferior to 5 nm able to combine PET/MRI imaging for tumor detection [1]. The size of this multimodal platform allows a good renal clearance [2]. The nanoparticles are composed of silica matrix functionalized by gadolinium chelate (DOTAGA-Gd), MRI positive contrast agent and free chelate (DOTAGA and NODAGA) for radiolabelling with isotopic radioactive such as 64Cu and 68Ga [3]. 68Ga isotope is an excellent candidate for nuclear imaging because of its availability. 64Cu has a long lifetime and can be used for Brachytherapy. Physical and chemical properties of the AGuIX ® coupled with 2,2’,2’’-(10-(2,6-dioxotetra hydro-2H-pyran-3-yl)-1,4,7,10-tet-
Source: EJNMMI Physics
Institutions: Lyon 1 Université, Centre National de la Recherche Scientifique, Matériaux Ingénierie et Science, Institut Lumière Matière, Institut National des Sciences Appliquées de Lyon, National Centre of Scientific Research "Demokritos", Institute of Nuclear & Radiological Sciences and Technology, Energy & Safety, Université de Bourgogne, Institut de Chimie Moléculaire de l'Université de Bourgogne, Academy of Athens, Biomedical Research Foundation of the Academy of Athens, National and Kapodistrian University of Athens, Aretaeio Hospital
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2000778413
